ArticleFrontiers in digital health2026
Framework for developing explainable artificial intelligence models for neglected tropical disease diagnosis in low-resource settings.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neglected tropical diseases (NTDs) continue to affect more than one billion people globally, disproportionately impacting populations living in low-resource settings characterized by limited diagnostic infrastructure, shortages of trained healthcare personnel, and restricted access to specialist services. Recent advances in artificial intelligence (AI), particularly deep learning and computer vision, have demonstrated significant potential for improving disease detection through the analysis of clinical images and microscopy data. However, despite encouraging diagnostic performance, many AI systems remain difficult to interpret, creating barriers to clinical trust, adoption, regulatory acceptance, and sustainable implementation in endemic regions. Main body: This narrative review examines the current landscape of AI applications in NTD diagnosis and critically evaluates the role of explainable artificial intelligence (XAI) in addressing challenges associated with transparency and trustworthiness. Evidence from studies involving malaria, schistosomiasis, soil-transmitted helminth infections, leishmaniasis, and skin-related NTDs demonstrates the growing capacity of AI to support diagnostic decision-making in resource-constrained environments. Nevertheless, persistent challenges related to limited datasets, poor data quality, algorithmic bias, model drift, infrastructure constraints, and ethical governance continue to impede translation into routine healthcare practice. Existing explainability approaches, including Gradient-weighted Class Activation Mapping (Grad-CAM), heatmaps, Shapley Additive Explanations (SHAP), Local Interpretable Model-Agnostic Explanations (LIME), and attention mechanisms, were reviewed to assess their relevance for NTD diagnostic systems. Framework development: Drawing upon current evidence in explainable AI, digital health implementation, and global health systems research, a seven-stage framework is proposed comprising: (1) problem definition, (2) data acquisition, (3) model development, (4) explainability layer integration, (5) clinical validation, (6) deployment in low-resource settings, and (7) continuous learning and monitoring. The framework embeds explainability throughout the AI development lifecycle to enhance transparency, accountability, clinical relevance, and equity. Conclusions: Artificial intelligence has considerable potential to improve NTD diagnosis in low-resource settings, but successful adoption depends on trust, transparency, and usability. The proposed framework provides a structured pathway for developing explainable AI systems that are technically robust, clinically meaningful, ethically responsible, and implementable within resource-constrained health systems, thereby supporting future NTD control and elimination efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.